Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis

Who May Qualify: •Patients with mild to moderate UC are diagnosed by history, clinical signs according to the Montreal classification of severity of ulcerative colitis and( Endoscopy, and biopsy) to establish the chronicity of inflammation and to exclude other causes of colitis. Who Should NOT Join This Trial: - Other inflammatory bowel diseases (CD). - History of serious hypersensitivity to empagliflozin or any component of the formulation. - Patients on dialysis. - Severe renal impairment (eGFR \<20 ml/minute/1.73m2) . - Chronic urinary tract infection. - Chronic genital infection. Always talk to your doctor about whether this trial is right for you.